𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase I trial of yttrium-90—labeled anti—prostate-specific membrane antigen monoclonal antibody J591 for androgen-independent prostate cancer: Milowsky MI, Nanus DM, Kostakoglu L, Vallabhajosula S, Goldsmith SJ, Bander NH, Division of Hematology and Medical Oncology, Department of Medicine, Weill Medical College of Cornell University, New York, NY. J Clin Oncol 2004;22:2522–31

✍ Scribed by Peter R. Carroll

Book ID
116955661
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
44 KB
Volume
22
Category
Article
ISSN
1078-1439

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Targeting metastatic prostate cancer wit
Targeting metastatic prostate cancer with radiolabeled monoclonal antibody J591 to the extracellular domain of prostate specific membrane antigen: Bander NH, Trabulsi EJ, Kostakoglu L, Yao D, Vallabhajosula S, Smith-Jones P, Joyce MA, Milowsky M, Nanus DM, Goldsmith SJ, Department of Urology, Division of Nuclear Medicine, New York-Presbyterian Hospital/Weill Medical College of Cornell University, New York, NY
✍ Mark P Ritter 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 14 KB